March 28, 2018 / 11:47 AM / 6 months ago

BRIEF-Crescita Therapeutics Q4 Net Loss Per Share $0.59

March 28 (Reuters) - Crescita Therapeutics Inc:

* CRESCITA THERAPEUTICS REPORTS 2017 FOURTH QUARTER AND YEAR END RESULTS

* QTRLY NET LOSS PER SHARE FROM CONTINUING OPERATIONS $0.59

* QTRLY REVENUE C$2.4 MILLION VERSUS C$2.2 MILLION

* CASH AND CASH EQUIVALENTS WERE $7.0 MILLION AS AT DECEMBER 31, 2017 COMPARED TO $9.8 MILLION AS AT DECEMBER 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below